Station X, a Silicon Valley based developer of software for scientific and clinical genome research, has just raised $5 million in its second funding round led by Runa Capital, a Russian early stage VC fund.
The two-year-old US start-up, which focuses on genome data analysis and visualization for clinical and research apps, is expected to funnel the money into further team-building and into providing a fast track for commercializing its flagship software product, ‘GenePool.’
GenePool is a software platform that seeks out tissue markers and enables the storage, analysis, and visualization of large quantities of genome data for tasks such as translational research, diagnostics tests and y-tracers development, as well as clinical genome analysis.
“Cracking the genetic code requires a combination of computational power and smart people with diverse skills and backgrounds. We are excited to add Runa Capital’s expertise in cloud computing to our existing team of investors,” said Dr. Richard D. Goold, a co-founder of Station X.
Andre Bliznyuk, a Runa Capital partner and now a board member at Station X, believes the American start-up “is poised to become a leader in foundational software for clinical genomics… Advances in cloud computing and Internet technologies coupled with cost-effective sequencing have created an unprecedented opportunity to produce capital-efficient genomic information products that can be validated and scaled very rapidly.”
Runa Capital is a $135 million VC fund set up in 2010, operating internationally from its Moscow headquaters.
